Drug Target Review: Pinpointing function in cancer T cells could be new immunotherapy
UC research has found that increasing a certain function in cancer T cells could mean a new therapy
A previously unknown T cell mechanism that could explain the reason behind decreased immune function in cancer patients has been discovered. According to University of Cincinnati researchers, their finding may present a new immunotherapeutic target for patients with head and neck cancers.
The study, led by Laura Conforti and Ameet Chimote, in the Division of Nephrology and Hypertension, UC Department of Internal Medicine, revealed that a reduced interaction between a molecule called calmodulin and the ion channel KCa3.1 in the immune cells of cancer patients plays an important role in the limited function of these cells. The team performed experiments on cytotoxic T cells taken from the blood of patients with head and neck cancer.
Featured photo courtesy of Laura Conforti and Ameet Chimote.
Related Stories
The next generation of care
April 15, 2024
University of Cincinnati student-led nonprofit organization Parkinson's Together takes a multidisciplinary approach to meeting the needs of patients with Parkinson's disease in their community. Now it's setting a model for student organizations across the country.
Healthline: UC expert discusses colorectal cancer
April 15, 2024
The University of Cincinnati's Carla Justiniano spoke with Healthline about colorectal cancer in an article about a woman diagnosed with cancer when she was seven months pregnant.
Professor receives prestigious 'Texty' award for textbook...
April 15, 2024
The University of Cincinnati's Patricia Tille has played a pivotal role and received a "Texty" award for developing and updating the textbook "Bailey & Scott's Diagnostic Microbiology."